EUVIMED · CrossrefZeitschrift
The Royal College of Radiologists Open
ISSN 2773-0662 · Elsevier BV
Neueste Artikel
AI readiness for healthcare provider organisations
Editorial
Myositis, myasthenia gravis, polyneuropathy and myocarditis: A life-threatening tetrad due to pembrolizumab
Pilot radiogenomic evaluation of colorectal cancer - Are there preoperative radiological features of the dMMR phenotype?
A comprehensive evaluation of MR-radiomics role in NAR score prediction in locally advanced rectal cancer
Effective selection of advanced cancer pancreas patients for mFOLFORINOX
Dosimetric assessment of rectal spacer hydrogels in low-dose-rate prostate brachytherapy
Efficacy and safety of AKT inhibitor and anti-androgen therapy in metastatic castration-resistant prostate cancer: a systematic review and meta-analysis
Survival outcomes for palliative pembrolizumab in head and neck cancer patients: real-world data from the north of England
Real-life efficacy data of trifluridine-tipiracil (LONSURF) in metastatic colorectal cancer patients in two UK oncology centres in the east of England
Outcomes of escalation: survival of non-elective oncology patients admitted to Nottingham City Hospital critical care department
MR delta-radiomics in prostate cancer: changes in the dominant intraprostatic lesion during different radiotherapy regimens
Religion and culture-related beliefs regarding cancer in a convenient sample of adults in Sri Lanka
Palbociclib real-world data collection to assess safety and efficacy in patients with metastatic HER2+ve breast cancer
Multiprofessional dedicated breast cancer adjuvant radiotherapy clinic: improved productivity and a streamlined patient pathway
Leadless permanent intraventricular pacemakers (MicraPPMTM) in patients undergoing adjuvant radiotherapy to the left breast: are manufacturer guideline tolerance doses easily attainable?
Developing an interspecialty cancer training programme curriculum for Europe: a quantitative survey
Outcomes for patients with metachronous oligometastatic lymph node disease treated with stereotactic ablative body radiotherapy
Pelvic radiation disease: defining incidence and outcomes from a specialist clinic
Cervical cancer treatment during COVID-19: a service review and discussion
Predicting anal cancer recurrence after radical chemoradiotherapy: a ten-year study based on tumour growth kinetics
Biochemical outcomes following radical radiotherapy for localised prostate cancer: comparative outcomes to national published data from the CHHiP trial
BIOPROP20: biologically optimised IMRT for prostate radiotherapy in 20 fractions. Hypofractionated radiotherapy with intraprostatic boosts to tumour nodules in men with intermediate- and high-risk prostate cancer: a phase II trial – five-year outcomes
The use of cemiplimab for metastatic or locally advanced cutaneous squamous cell carcinoma at the Oxford University Hospitals 2019–2022
Stereotactic radiotherapy for HCC: real-world outcomes and multidisciplinary working
Personalised follow-up for patients with head and neck cancer: quality of life and patient experience
Development of a structured viva voce in radiation therapy education: a clinical and academic collaboration
Use of neoadjuvant endocrine therapy with cyclin-dependent kinase 4/6 inhibitors to downstage inoperable, non-metastatic, oestrogen receptor positive, HER2-negative breast cancer
To assess the diagnostic accuracy of Doppler indices in differentiating benign and malignant ovarian masses
Developing a comprehensive education programme for doctors undertaking an oncology rotation at a specialist oncology centre
EUVIMED